G. Kosmadakis, L. Derain Dubourg, M. Lauverjat, C. Bergoin, C. Chambrier
{"title":"Cystatine C comme marqueur de la fonction rénale chez les patients atteints d’insuffisance intestinale chronique sous nutrition parentérale de longue durée","authors":"G. Kosmadakis, L. Derain Dubourg, M. Lauverjat, C. Bergoin, C. Chambrier","doi":"10.1016/j.nupar.2023.03.125","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.125","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134122923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
R.M. Haws, A.M. Haqq, K. Clément, W.K. Chung, H. Dollfus, E. Forsythe, G.A. Martos-Moreno, J.A. Yanovski, G. Yuan, J. Argente
{"title":"Impact du traitement par setmélanotide sur les paramètres lipidiques et les signes vitaux chez les patients atteints du syndrome de Bardet-Biedl dans un essai de phase 3","authors":"R.M. Haws, A.M. Haqq, K. Clément, W.K. Chung, H. Dollfus, E. Forsythe, G.A. Martos-Moreno, J.A. Yanovski, G. Yuan, J. Argente","doi":"10.1016/j.nupar.2023.03.156","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.156","url":null,"abstract":"Le syndrome de Bardet-Biedl (SBB) est une maladie génétique rare associée à une hyperphagie et une obésité sévère et précoce, augmentant le risque de comorbidités liées au syndrome métabolique. Dans un essai de phase 3, setmélanotide (SET) a été associé à une réduction de l’indice de masse corporelle (IMC) et de l’hyperphagie. L’impact sur les profils lipidiques et les signes vitaux a également été évalué. Des patients SBB souffrant d’obésité, avec un poids > 97e percentile (patients de 6 à 15 ans) et un IMC ≥ 30 kg/m2 (patients ≥ 16 ans) ont été inclus. Le profil lipidique à jeun a été évalué avant l’administration de SET et après 52 semaines de traitement. À l’inclusion (n = 32), l’IMC moyen (écart-type [ET]) était de 46,4 (5,8) kg/m2 pour les patients ≥ 18 ans et de 37,4 (9,4) kg/m2 pour les patients < 18 ans. Après 52 semaines de traitement par SET, la variation moyenne (ET) de l’IMC était de −9,1 % (6,8 %) pour les patients ≥ 18 ans et la variation moyenne (ET) du score z de l’IMC était de −0,75 (0,46) pour les patients < 18 ans. Les variations moyennes (ET) du cholestérol total, du HDL cholestérol, du LDL cholestérol et des triglycérides étaient respectivement de −6,1 % (10,6 %), 5,3 % (11,6 %), −7,8 % (16,8 %) et −9,6 % (32,5 %). Aucune variation systématique de la pression artérielle ou de la fréquence cardiaque n’a été identifiée. Cette analyse confirme que setmélanotide est un traitement efficace de l’obésité et de l’atteinte métabolique chez les patients atteints de SBB.","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"252 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136338570","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
N. Navarre, C. Anfossi, D. Baltyde, A. Lamoliate, B. Tressières, O. Parant, M. Lalanne-Mistrih
{"title":"Excès de prise de poids et ses facteurs de risque au cours de la grossesse, en fonction de l’indice de masse corporelle pré-conceptionnel : étude pilote monocentrique","authors":"N. Navarre, C. Anfossi, D. Baltyde, A. Lamoliate, B. Tressières, O. Parant, M. Lalanne-Mistrih","doi":"10.1016/j.nupar.2023.03.164","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.164","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"19 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131336814","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E. Thomas-Johansson, S. Wharton, R. Batterham, M. Bhatta, S. Buscemi, L. Christensen, J. Frías, E. Jódar, K. Kandler, T. Garvey
{"title":"Effet à deux ans du sémaglutide 2,4 mg sur le contrôle de la prise alimentaire chez des adultes en situation de surpoids ou d’obésité","authors":"E. Thomas-Johansson, S. Wharton, R. Batterham, M. Bhatta, S. Buscemi, L. Christensen, J. Frías, E. Jódar, K. Kandler, T. Garvey","doi":"10.1016/j.nupar.2023.03.152","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.152","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"127 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"115628186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
O. Habanjar, A. Maurin, C. Vituret, C. Vachias, C. Decombat, M. Diab-Assaf, F. Caldefie-Chézet, L. Delort
{"title":"Obésité et progression tumorale : optimisation d’un modèle 3D de tumoroïdes bicellulaires fluorescents mimant le cancer canalaire in situ dans un microenvironnement adipeux et inflammatoire","authors":"O. Habanjar, A. Maurin, C. Vituret, C. Vachias, C. Decombat, M. Diab-Assaf, F. Caldefie-Chézet, L. Delort","doi":"10.1016/j.nupar.2023.03.140","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.140","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"5 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114225007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
C. Lefèbvre, A. Goichon, V. Dreux, C.E. Breemeersch, C. Guérin, P. Déchelotte, M. Coëffier
{"title":"Effets sexe-dépendants d’une supplémentation en glutamine sur le contrôle glycémique et la perméabilité intestinale chez la souris obèse soumise à un stress","authors":"C. Lefèbvre, A. Goichon, V. Dreux, C.E. Breemeersch, C. Guérin, P. Déchelotte, M. Coëffier","doi":"10.1016/j.nupar.2023.03.159","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.159","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"39 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114499696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rebecca Bendjama, M. Bentaleb, I. Sersar, M. Bencharif
{"title":"Santé du nouveau-né de mère atteinte d’un diabète gestationnel – étude de 131 cas","authors":"Rebecca Bendjama, M. Bentaleb, I. Sersar, M. Bencharif","doi":"10.1016/j.nupar.2023.03.174","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.174","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"25 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116491715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
M. Chourak, S. Lanasri, A. Haraoubia, C. Benia, S. Yahiat, O. Hadjoudj
{"title":"L’allaitement maternel chez le prématuré au CHU Nefissa Hammoud","authors":"M. Chourak, S. Lanasri, A. Haraoubia, C. Benia, S. Yahiat, O. Hadjoudj","doi":"10.1016/j.nupar.2023.03.176","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.176","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"100 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"121459612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Farooqi, J. Argente, E. van den Akker, G. Yuan, O. Ohayon, S. Brossard, M. Wabitsch
{"title":"EMANATE : design de l’étude de phase 3 contrôlée par placebo évaluant l’efficacité et la sécurité de setmélanotide chez les patients souffrant d’obésité génétique liée a un déficit hétérozygote en POMC, LEPR, SRC1 ou SH2B1","authors":"S. Farooqi, J. Argente, E. van den Akker, G. Yuan, O. Ohayon, S. Brossard, M. Wabitsch","doi":"10.1016/j.nupar.2023.03.158","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.158","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"73 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122578686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J. Morcel, L. Béghin, F. Flamein, L. Zambelli, A. Vandewiele, C. Garabedian, F. Gottrand, E. Hermann, D. Ley
{"title":"Impact de la nutrition pendant les 1000 premiers jours sur la santé intestinale de l’enfant : caractérisation de la cohorte PENSINE","authors":"J. Morcel, L. Béghin, F. Flamein, L. Zambelli, A. Vandewiele, C. Garabedian, F. Gottrand, E. Hermann, D. Ley","doi":"10.1016/j.nupar.2023.03.173","DOIUrl":"https://doi.org/10.1016/j.nupar.2023.03.173","url":null,"abstract":"","PeriodicalId":419185,"journal":{"name":"Nutrition Clinique et Métabolisme","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131203951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}